Altered EEG spectral activity and attentional behavioral deficits following prolonged febrile seizures: a pilot study

Sarah Lippé1, Marie-Sylvie Roy, Claudine Arcand

  • 1Department of Psychology, University of Montreal, Montreal, Canada.

Insights

Febrile seizures (FSs) in infants can alter brain activity. Prolonged FSs showed persistent spectral density changes, suggesting potential long-term neurological impacts and affecting attentional capacities in children.

Area of Science:

  • Pediatric Neurology
  • Neurophysiology
  • Developmental Neuroscience

Background:

  • The long-term neurological consequences of febrile seizures (FSs) in infants remain unclear.
  • Non-invasive brain function markers are needed to predict FS outcomes.
  • Pattern visual evoked potentials (pVEPs) offer a potential tool for assessing infant brain function.

Purpose of the Study:

  • To investigate brain function markers in infants following febrile seizures using pVEPs.
  • To assess the impact of FS severity and duration on neurophysiological measures.
  • To correlate neurophysiological findings with cognitive and behavioral outcomes in children.

Main Methods:

  • Recorded pVEPs in 18 infants with FSs and age-matched controls.
  • Analyzed spectral density and coherence of pVEP responses at different time points post-seizure.
  • Administered cognitive (Bayley, Stanford-Binet) and behavioral (Achenbach) assessments.

Main Results:

  • pVEP responses and coherence did not differ significantly between FS and control groups.
  • Increased delta band activity was observed in all FS groups.
  • Reduced high-frequency density was noted in prolonged FS groups up to 39 months post-seizure.
  • FS infants exhibited average cognitive development but lower attentional capacities.

Conclusions:

  • Persistent spectral density changes in prolonged FS may indicate seizure-induced brain alterations or genetic factors.
  • These findings suggest potential neurophysiological markers for predicting behavioral deficits or epilepsy risk.
  • Further research is required to validate these markers for clinical prediction.